Subtype
Breast Carcinoma
CI-CAN-00000594Explore in graph →
873 active trials12 approved drugs113 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000594Explore in graph →
Clinical trials
2,394 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (365)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02580448 | CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448)(CLARITY-01) | completed | Phase 1 / Phase 2 | 175 | Innocrin PharmaceuticalINDUSTRY | 1 | Feb 1, 2019 | clinicaltrials |
| NCT02773784 | Comparison of CNB and Surgical Specimens for ER, PgR, HER2 Status and Ki67 Index in Invasive Breast Cancer. | completed | — | 314 | Peking UniversityOTHER | 1 | Jan 18, 2019 |
| clinicaltrials |
| NCT02599194 | 18F-FSPG PET/CT for Cancer Patients on Therapy | completed | Phase 2 | 7 | Andrei IagaruOTHER | 1 | Jan 3, 2019 | clinicaltrials |
| NCT01277757 | Akt Inhibitor MK2206 in Treating Patients With Advanced Breast Cancer | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 1 | Dec 19, 2018 | clinicaltrials |
| NCT00425672 | ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment | completed | Phase 1 / Phase 2 | 15 | University of WashingtonOTHER | 1 | Dec 5, 2018 | clinicaltrials |
| NCT00733408 | Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer | completed | Phase 2 | 59 | University of WashingtonOTHER | 1 | Dec 4, 2018 | clinicaltrials |
| NCT00869206 | Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement | completed | Phase 3 | 1,822 | Alliance for Clinical Trials in OncologyOTHER | 2 | Nov 7, 2018 | clinicaltrials |
| NCT01632332 | Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer | completed | Phase 1 | 22 | Mayo ClinicOTHER | 1 | Oct 9, 2018 | clinicaltrials |
| NCT02521961 | Support Group Program in Improving Quality of Life in Underserved Urban Latina Breast Cancer Survivors | completed | N/A | 10 | Fred Hutchinson Cancer CenterOTHER | 1 | Oct 5, 2018 | clinicaltrials |
| NCT01986426 | LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab | completed | Phase 1 | 80 | Lytix Biopharma ASINDUSTRY | 5 | Oct 3, 2018 | clinicaltrials |
| NCT01638247 | Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients(MALE) | completed | Phase 3 | 56 | GBG Forschungs GmbHOTHER | 1 | Sep 19, 2018 | clinicaltrials |
| NCT01194440 | Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms | completed | Phase 2 | 63 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Sep 12, 2018 | clinicaltrials |
| NCT01493310 | Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer | completed | Phase 1 | 9 | University of ChicagoOTHER | 1 | Sep 12, 2018 | clinicaltrials |
| NCT02046421 | Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer | completed | Phase 1 | 31 | University of ChicagoOTHER | 1 | Sep 11, 2018 | clinicaltrials |
| NCT02224807 | Effects of Diet and Exercise on Ductal Carcinoma in Situ(DCIS) | completed | N/A | 32 | University of Alabama at BirminghamOTHER | 1 | Aug 31, 2018 | clinicaltrials |
| NCT02225470 | Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes | completed | Phase 3 | 530 | Eisai Co., Ltd.INDUSTRY | 1 | Aug 28, 2018 | clinicaltrials |
| NCT02150525 | Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors | completed | Phase 2 | 52 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Aug 9, 2018 | clinicaltrials |
| NCT03000764 | RNA and Heat Shock Protein Biomarkers in Radiation-induced Fibrosis in Breast Cancer(SPLICI-Rad) | completed | N/A | 20 | Institut de Cancérologie de LorraineOTHER | 1 | Aug 8, 2018 | clinicaltrials |
| NCT03408769 | Metastatic Breast Carcinoma and Women Sexual Quality of Life(SexoMBC) | completed | — | 30 | Institut de Cancérologie de LorraineOTHER | 1 | Aug 8, 2018 | clinicaltrials |
| NCT00986609 | MUC1 Vaccine for Triple-negative Breast Cancer | completed | Early Phase 1 | 29 | Joseph Baar, MD, PhDOTHER | 1 | Jul 23, 2018 | clinicaltrials |
| NCT01344031 | MK2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole and Fulvestrant in Treating Postmenopausal Women With Metastatic Breast Cancer | completed | Phase 1 | 31 | National Cancer Institute (NCI)NIH | 1 | Jul 23, 2018 | clinicaltrials |
| NCT03576521 | Evaluation of Ocoxin®-Viusid® in Breast Cancer | completed | Phase 2 | 120 | Catalysis SLINDUSTRY | 1 | Jul 3, 2018 | clinicaltrials |
| NCT00892736 | Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy | completed | Phase 1 | 98 | National Cancer Institute (NCI)NIH | 1 | Jun 29, 2018 | clinicaltrials |
| NCT02060253 | Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer | completed | Phase 1 | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 14, 2018 | clinicaltrials |
| NCT00699491 | Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Jun 13, 2018 | clinicaltrials |
| NCT01091428 | Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer | completed | Phase 2 | 191 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Jun 4, 2018 | clinicaltrials |
| NCT03539965 | Triple-negative Breast Cancer: a New Perspective on Biomarkers(TNBCbrazil) | completed | — | 239 | Instituto Nacional de Cancer, BrazilOTHER_GOV | 1 | May 31, 2018 | clinicaltrials |
| NCT02270372 | Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast Cancer | completed | Phase 1 | 22 | Cascadian Therapeutics Inc.INDUSTRY | 1 | May 17, 2018 | clinicaltrials |
| NCT01928186 | FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer | completed | N/A | 28 | University of WashingtonOTHER | 1 | May 15, 2018 | clinicaltrials |
| NCT01091454 | Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 48 | Alliance for Clinical Trials in OncologyOTHER | 1 | May 8, 2018 | clinicaltrials |
| NCT03052907 | Breast Screening & Patient Navigation (BSPAN2): Evaluating a De-Centralized Regional Delivery System for Rural Underserved | completed | N/A | 18,540 | University of Texas Southwestern Medical CenterOTHER | 0 | Apr 23, 2018 | clinicaltrials |
| NCT00555152 | Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ | completed | N/A | 22 | National Cancer Institute (NCI)NIH | 1 | Apr 20, 2018 | clinicaltrials |
| NCT01042535 | Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 44 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Apr 11, 2018 | clinicaltrials |
| NCT01624441 | Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Mar 30, 2018 | clinicaltrials |
| NCT01520389 | Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment | completed | Phase 1 | 112 | Merrimack PharmaceuticalsINDUSTRY | 1 | Mar 21, 2018 | clinicaltrials |
| NCT00194779 | Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery | completed | Phase 2 | 50 | University of WashingtonOTHER | 1 | Mar 12, 2018 | clinicaltrials |
| NCT00707707 | Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer | completed | Phase 1 | 19 | AstraZenecaINDUSTRY | 4 | Mar 6, 2018 | clinicaltrials |
| NCT01723943 | Educational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer Patients | completed | N/A | 108 | University of WashingtonOTHER | 1 | Feb 8, 2018 | clinicaltrials |
| NCT01871116 | POWER-remote Weight Loss Program in Early Stage Breast Cancer | completed | N/A | 96 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT00821964 | Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer | completed | Phase 2 | 15 | University of WashingtonOTHER | 1 | Jan 2, 2018 | clinicaltrials |
| NCT01145430 | Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer | completed | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 1 | Dec 22, 2017 | clinicaltrials |
| NCT00998036 | Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors | completed | Phase 1 | 9 | Columbia UniversityOTHER | 1 | Dec 13, 2017 | clinicaltrials |
| NCT00118157 | Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen | completed | Phase 2 | 19 | National Cancer Institute (NCI)NIH | 1 | Dec 4, 2017 | clinicaltrials |
| NCT01853306 | A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors | completed | Phase 1 | 71 | AbbVieINDUSTRY | 0 | Nov 21, 2017 | clinicaltrials |
| NCT03003611 | Observational Trial on the Impact of Hypnose Used as a Sedation in Oncology Surgery in Breast Cancer | completed | — | 150 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Nov 13, 2017 | clinicaltrials |
| NCT02556632 | Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer(Curcumin-II) | completed | Phase 2 | 191 | Gary MorrowOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT01307891 | Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer | completed | Phase 2 | 64 | University of Alabama at BirminghamOTHER | 1 | Oct 26, 2017 | clinicaltrials |
| NCT03304171 | Overall Diet Quality and Breast Cancer Risk | completed | — | 96,959 | University of California, IrvineOTHER | 0 | Oct 11, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Feb 1, 2019source: clinicaltrials